About Salus Group
At Salus, we put patients and partners at the center of everything we do.
Salus is one of the leading independent pharmaceutical commercialization and distribution platforms in Central and Eastern Europe (CEE), supporting biotech, pharmaceutical, and MedTech companies seeking a trusted regional partner to enter, expand, or strengthen their presence across 18 CEE markets.
Scale, Expertise, and Integrated Capabilities
With 700 professionals and €696 million in revenue in 2025, Salus combines deep expertise in regulatory affairs, market access, pricing and reimbursement, medical affairs, and commercial operations with a robust pharmaceutical supply chain and distribution infrastructure.
A Powerful Go-to-Market Platform Across CEE
Our integrated go-to-market model enables efficient product launches, strong market uptake, and sustainable business growth across diverse healthcare systems. All regional activities are strategically coordinated from our headquarters in Ljubljana, Slovenia, ensuring alignment, speed, and consistent execution across 18 CEE markets.
Driving Access to Innovative Therapies
Our teams bring proven experience in specialty pharmaceuticals, rare diseases, hospital products, and advanced medical technologies — ensuring innovative therapies and healthcare solutions reach patients efficiently, responsibly, and with measurable commercial impact throughout Central and Eastern Europe.